There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Penumbra Inc. (PEN) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $264.12. The Penumbra Inc. has recorded 2,984 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Penumbra, Inc. to Present at Upcoming Investor Conferences.
As a NYSE listed company, PEN falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $264.12 and fluctuated between $267.37 as its day high and $262.62 as its day low. The current market capitalization of Penumbra Inc. is $10.17B. A total of 0.23 million shares were traded on the day, compared to an average of 371.92K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, PEN has seen 2 BUY and 21 SELL insider trades, representing the acquisition of 19,332 and the disposition of 20,922 shares. Over the last 12 months, there were 21 BUYs and 102 SELLs from insiders. Insiders purchased 67,240 shares during that period but sold 91,718.
In the most recent transaction, Roberts Johanna sold 600 shares of PEN for 249.85 per share on Aug 14. After the transaction, the EVP, Gen. Counsel & Secretary now owns 64,837 company shares. In a previous transaction on Aug 11, Elsesser Adam sold 9,666 shares at 247.21 per share. PEN shares that CEO and President owns now total 0.
Among the insiders who sold shares, Kassing Don W. disposed of 323 shares on Aug 08 at a per-share price of $251.00. This resulted in the Director holding 1,902 shares of PEN after the transaction. In another insider transaction, Wilder Thomas sold 340 shares at $253.48 per share on Aug 07. Company shares held by the Director now total 340.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for PEN in the last 3 months, the mean price target is $341.50 with high estimates of $390.00 and low estimates of $308.00. In terms of 52-week highs and lows, PEN has a high of $348.67 and a low of $144.76.
As of this writing, PEN has an earnings estimate of $0.45 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $0.53 per share and a lower estimate of $0.4. The company reported an EPS of $0.23 in the last quarter, which was 109.10% higher than expectations of $0.11.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. PEN’s latest balance sheet shows that the firm has $254.88M in Cash & Short Term Investments as of fiscal 2021. There were $173.55M in debt and $123.20M in liabilities at the time. Its Book Value Per Share was $27.83, while its Total Shareholder’s Equity was $953.93M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PEN is Buy with a score of 4.77.